The structure of the galectin domain reveals an interaction interface between its two carbohydrate recognition selleck products domains, locating both sugar binding sites face to face. Sequence evidence suggests other tandem-repeat galectins have the same arrangement. We show that the galectin
domain binds carbohydrates containing lactose and N-acetyl-lactosamine units, and we present structures of the galectin domain with lactose, N-acetyl-lactosamine, 3-aminopropyl-lacto-N-neotetraose, and 2-aminoethyl-tri(N-acetyllactosamine), confirming the domain as a bona fide galectin domain.”
“Although resting-state functional magnetic resonance imaging has shown altered functional connectivity between visual and other brain areas in the early blind individuals, it cannot answer which brain area’s local activities are changed. In this study, regional homogeneity, a measure of the homogeneity of the local blood oxygen level-dependent signals, was used for the first time to investigate the changes in the
resting-state brain activity in the early blind individuals. Compared with age-matched and sex-matched sighted individuals, the early blind individuals showed increased regional homogeneity only in the occipital areas, which might be explained by the abnormal cortical development and/or experience-dependent plasticity, resulted from an early visual deprivation. NeuroReport 22:190-194 click here (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.”
“Bone marrow stromal antigen 2 (BST-2/tetherin) is a cellular membrane protein that inhibits the release of HIV-1. We show for the first time, using infectious viruses, that BST-2 also inhibits egress of arenaviruses but has no effect on filovirus replication and spread. Specifically, infectious Lassa virus (LASV) release significantly decreased or increased in human cells
in which BST-2 was either stably expressed or knocked down, respectively. In contrast, replication and spread OICR-9429 order of infectious Zaire ebolavirus (ZEBOV) and Lake Victoria marburgvirus (MARV) were not affected by these conditions. Replication of infectious Rift Valley fever virus (RVFV) and cowpox virus (CPXV) was also not affected by BST-2 expression. Elevated cellular levels of human or murine BST-2 inhibited the release of virus-like particles (VLPs) consisting of the matrix proteins of multiple highly virulent NIAID Priority Pathogens, including arenaviruses (LASV and Machupo virus [MACV]), filoviruses (ZEBOV and MARV), and paramyxoviruses (Nipah virus). Although the glycoproteins of filoviruses counteracted the antiviral activity of BST-2 in the context of VLPs, they could not rescue arenaviral (LASV and MACV) VLP release upon BST-2 overexpression.